Bank Julius Baer & Co’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.17K | Hold |
800
| – | – | ﹤0.01% | 656 |
|
|
2025
Q4 | $4.9K | Hold |
800
| – | – | ﹤0.01% | 626 |
|
|
2025
Q3 | $14.7K | Sell |
800
-1,500
| -65% | -$24.1K | ﹤0.01% | 633 |
|
|
2025
Q2 | $29.9K | Hold |
2,300
| – | – | ﹤0.01% | 568 |
|
|
2025
Q1 | $24.4K | Buy |
2,300
+216
| +10% | +$3.43K | ﹤0.01% | 571 |
|
|
2024
Q4 | $39K | Sell |
2,084
-23,201
| -92% | -$437K | ﹤0.01% | 575 |
|
|
2024
Q3 | $696K | Sell |
25,285
-1,971
| -7% | -$42.2K | ﹤0.01% | 309 |
|
|
2024
Q2 | $739K | Sell |
27,256
-16,506
| -38% | -$501K | ﹤0.01% | 255 |
|
|
2024
Q1 | $1.48M | Sell |
43,762
-3,470
| -7% | -$123K | 0.01% | 242 |
|
|
2023
Q4 | $1.49M | Sell |
47,232
-11,028
| -19% | -$262K | 0.01% | 253 |
|
|
2023
Q3 | $1.49M | Sell |
58,260
-1,569
| -3% | -$48.3K | 0.01% | 225 |
|
|
2023
Q2 | $1.72M | Sell |
59,829
-10,241
| -15% | -$279K | 0.01% | 226 |
|
|
2023
Q1 | $1.68M | Buy |
70,070
+3,746
| +6% | +$67.2K | 0.01% | 219 |
|
|
2022
Q4 | $1.13M | Buy |
66,324
+6,707
| +11% | +$117K | 0.01% | 251 |
|
|
2022
Q3 | $884K | Sell |
59,617
-65,221
| -52% | -$1.09M | 0.01% | 272 |
|
|
2022
Q2 | $1.97M | Sell |
124,838
-92,425
| -43% | -$1.81M | 0.01% | 209 |
|
|
2022
Q1 | $5.86M | Sell |
217,263
-48,907
| -18% | -$1.25M | 0.04% | 163 |
|
|
2021
Q4 | $9.85M | Sell |
266,170
-414,079
| -61% | -$16.9M | 0.05% | 154 |
|
|
2021
Q3 | $32.5M | Sell |
680,249
-22,529
| -3% | -$1.01M | 0.2% | 87 |
|
|
2021
Q2 | $23.8M | Buy |
702,778
+287,237
| +69% | +$9.72M | 0.15% | 114 |
|
|
2021
Q1 | $17.2M | Buy |
415,541
+79,464
| +24% | +$4.74M | 0.13% | 124 |
|
|
2020
Q4 | $14.6M | Buy |
336,077
+200,809
| +148% | +$13.6M | 0.12% | 121 |
|
|
2020
Q3 | $5.9M | Buy |
+135,268
| New | +$6.71M | 0.06% | 149 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
